ITMCTR2100004590招募中1 期
A randomized, double-blind, placebo-parallel controlled, multicenter phase IIa clinical trial of Bailing Tongfengxiao granules in the treatment of acute gouty arthritis (dampness-heat stasis syndrome)
Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •(1) Those who voluntarily participate in the test and sign the informed consent;
- •(2) Aged between 18 and 65 (including 18 and 65);
- •(3) Meet the Western diagnostic criteria for acute gouty arthritis (Gout Classification Standards, 2015, developed by the American College of Rheumatology (ACR) and the European League Against Rheumatology (EULAR));
- •(4) In line with the TCM syndrome differentiation criteria of dampness-heat stasis (refer to the Standards for Diagnosis and Efficacy of TCM Diseases and Syndromes formulated by the State Administration of Traditional Chinese Medicine in 1994 and the Guiding Principles for Clinical Research of New Chinese Drugs formulated by the Ministry of Health of the People's Republic of China in 1995);
- •(5) The pain site of this acute attack is the lower limb joint;
- •(6) The acute onset is less than 48 hours;
- •(7) Pain VAS score >= 4;
- •(8) If you are on uric-lowering therapy, you must take the drug at a steady dose for 2 weeks prior to randomization and do not change your treatment regimen during the study period;
- •(9) Agree to use effective non-drug contraceptives during the trial.
排除标准
- •(1) Intermittent gout or chronic tophi arthritis;
- •(2) advanced arthritis severe deformity, stiffness, loss of labor;
- •(3) complicated with other arthritis such as acute rheumatic fever, infectious arthritis, traumatic arthritis, pseudogout, rheumatoid arthropathy or spinal arthritis, or complicated with soft tissue swelling and pain of lower limbs such as erysipelas, phlebitis of lower extremities, diabetic foot, or complicated with other diseases that may affect the observation of curative effect;
- •(4) secondary gout;
- •(5) Patients with serious cardiovascular, cerebrovascular, liver, kidney and other serious diseases or psychosis;
- •(6) ALT, AST or TBIL are 1.5 ULN, or SCR is 1.2 ULN;
- •(7) Peripheral blood WBC < 3.5 x 10^9/L, or with definite anemia (HGB < 90g/L), or PLT < 80 x 10^9/L, or other blood system diseases;
- •(8) Use of drugs affecting efficacy observation during the first 2 weeks of randomization, including (meeting any of the following criteria):
- •1) Aspirin: not taking drugs regularly; Or regular daily dose of > 100mg;
- •2) Diuretics and other drugs that affect uric acid metabolism;
- •3) Colchicine, NSAIDs, glucocorticoids;
- •(9) After this acute attack, use acupuncture and moxibustion, pricking blood and other therapeutic therapies;
- •(10) Pregnant or lactating women;
- •(11) During the trial period and within 3 months after the last administration of the experimental drug, those who had a family planning plan;
- •(12) Allergic to this product or its ingredients;
- •(13) Suspecting or having a history of alcohol and drug abuse;
- •(14) Patients who participated in other clinical trials within the last 3 months;
- •(15) Investigator considers that other factors (such as conditions that may cause subjects to fail to complete the study or pose significant risks to subjects) are not appropriate for participants to participate in this clinical trial.
研究者
相似试验
尚未招募
3 期
A randomized, double-blind, placebo-parallel controlled, multicenter Phase III clinical trial of efficacy and safety of Xiao'er Huangjin Zhike Granules in the treatment of acute bronchitis cough&#Acute bronchitis cough in childrenITMCTR2200005488Beijing Children's Hospital,Capital Medical University
招募中
不适用
A randomized, double-blind, placebo-parallel controlled, multicenter clinical trial of efficacy and safety of Guhong injection in the treatment of unstable angina pectorisITMCTR2100004684Beijing Chaoyang Hospital, Capital Medical University
招募中
4 期
A randomized, double-blind, placebo-parallel-controlled, multicenter clinical trial reevaluating the efficacy and safety of Qiye Shenan dropping pill in the treatment of insomnia (qi deficiency syndrome)AnhypnosisITMCTR2100004546Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences
尚未招募
4 期
A randomized, double-blind, placebo parallel-controlled, multi-center clinical trial to evaluate the effectiveness and safety of Tanyin Pills in the treatment of stable COPD (spleen-kidney yang deficiency, phlegm-yin obstructing lung syndrome) with AECOPD as the endpoint eventCOPD stable periodITMCTR2100005065West China Hospital of Sichuan University
尚未招募
4 期
A randomized, double-blind, placebo parallel controlled clinical trial of Shuanghua Baihe Tablets in the treatment of recurrent aphthous ulcerRecurrent aphthous ulcerITMCTR2000003541Peking University School and Hospital of Stomatology